Drugs / ENX-205
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07253246 | Mar 2025 → May 2026 | — | Engrail Therapeutics INC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ENX-205 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07253246 ↗ |
| Route | Oral | “oral solution” NCT07253246 ↗ |